JP2013511566A5 - - Google Patents

Download PDF

Info

Publication number
JP2013511566A5
JP2013511566A5 JP2012540414A JP2012540414A JP2013511566A5 JP 2013511566 A5 JP2013511566 A5 JP 2013511566A5 JP 2012540414 A JP2012540414 A JP 2012540414A JP 2012540414 A JP2012540414 A JP 2012540414A JP 2013511566 A5 JP2013511566 A5 JP 2013511566A5
Authority
JP
Japan
Prior art keywords
protein
factor
pegylated protein
buffer
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012540414A
Other languages
English (en)
Japanese (ja)
Other versions
JP5827955B2 (ja
JP2013511566A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/068112 external-priority patent/WO2011064247A1/en
Publication of JP2013511566A publication Critical patent/JP2013511566A/ja
Publication of JP2013511566A5 publication Critical patent/JP2013511566A5/ja
Application granted granted Critical
Publication of JP5827955B2 publication Critical patent/JP5827955B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012540414A 2009-11-24 2010-11-24 Peg化タンパク質の精製方法 Active JP5827955B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09176881 2009-11-24
EP09176881.2 2009-11-24
US26448609P 2009-11-25 2009-11-25
US61/264,486 2009-11-25
PCT/EP2010/068112 WO2011064247A1 (en) 2009-11-24 2010-11-24 Method of purifying pegylated proteins

Publications (3)

Publication Number Publication Date
JP2013511566A JP2013511566A (ja) 2013-04-04
JP2013511566A5 true JP2013511566A5 (https=) 2014-01-16
JP5827955B2 JP5827955B2 (ja) 2015-12-02

Family

ID=41401820

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012540414A Active JP5827955B2 (ja) 2009-11-24 2010-11-24 Peg化タンパク質の精製方法

Country Status (5)

Country Link
US (1) US8697844B2 (https=)
EP (1) EP2504349B1 (https=)
JP (1) JP5827955B2 (https=)
CN (2) CN102639553A (https=)
WO (1) WO2011064247A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2670618C (en) 2006-12-15 2016-10-04 Baxter International Inc. Factor viia- (poly) sialic acid conjugate having prolonged in vivo half-life
CN106110311A (zh) 2009-07-27 2016-11-16 百深公司 凝血蛋白缀合物
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
CN102497884A (zh) 2009-07-27 2012-06-13 巴克斯特国际公司 凝血蛋白缀合物
KR101912335B1 (ko) 2009-07-27 2018-10-26 리폭센 테크놀로지즈 리미티드 비혈액 응고 단백질의 글리코폴리시알화
HUE049352T2 (hu) 2010-12-22 2020-09-28 Baxalta GmbH Anyagok és módszerek egy vízoldható zsírsavszármazéknak egy fehérjéhez való konjugálására
KR102020995B1 (ko) * 2017-10-30 2019-09-16 한국코러스 주식회사 콜로니자극인자와 폴리올이 접합된 접합물을 고수율로 제조하는 방법
HRP20220041T1 (hr) 2017-12-29 2022-04-15 F. Hoffmann - La Roche Ag Postupak za dobivanje pegiliranog proteinskog pripravka
CN111741770A (zh) * 2017-12-29 2020-10-02 豪夫迈·罗氏有限公司 用于提供聚乙二醇化蛋白质组合物的方法
WO2019129878A1 (en) * 2017-12-29 2019-07-04 F. Hoffmann-La Roche Ag Process for providing pegylated protein composition
WO2022120547A1 (zh) 2020-12-08 2022-06-16 通化安睿特生物制药股份有限公司 纯化重组蛋白的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
AU6255096A (en) 1995-06-07 1996-12-30 Mount Sinai School Of Medicine Of The City University Of New York, The Pegylated modified proteins
PT1308456E (pt) * 1998-05-06 2007-12-03 Genentech Inc Purificação de anticorpos por cromatografia de permuta iónica
EP1500661A1 (en) 1998-06-01 2005-01-26 Genetech, Inc. Separation of protein monomers from aggregates by use of ion-exchange chromatography
US7179617B2 (en) 2001-10-10 2007-02-20 Neose Technologies, Inc. Factor IX: remolding and glycoconjugation of Factor IX
US7795210B2 (en) 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
EP2042196B1 (en) 2001-10-10 2016-07-13 ratiopharm GmbH Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
US7265084B2 (en) 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7473680B2 (en) 2001-11-28 2009-01-06 Neose Technologies, Inc. Remodeling and glycoconjugation of peptides
US7470779B2 (en) * 2002-09-20 2008-12-30 Pfizer Inc. Process for decreasing aggregate levels of pegylated protein
EP2055189A1 (en) 2003-04-09 2009-05-06 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
AU2004296860B2 (en) 2003-12-03 2010-04-22 Novo Nordisk A/S Glycopegylated factor IX
EP1891231A4 (en) 2005-05-25 2011-06-22 Novo Nordisk As GLYCOPEGYLATED FACTOR IX
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
EP1937719A4 (en) * 2005-08-19 2010-11-24 Novo Nordisk As GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA
WO2008104372A1 (en) 2007-02-28 2008-09-04 Baxter International Inc. Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules
WO2008119815A1 (en) 2007-04-02 2008-10-09 Novo Nordisk A/S Subcutaneous administration of coagulation factor ix

Similar Documents

Publication Publication Date Title
JP2013511566A5 (https=)
JP2013514073A5 (https=)
EA201171199A1 (ru) Способ очистки рекомбинантного фсг
ES2923018T3 (es) Métodos de purificación de ARN
BR112013030628A2 (pt) "métodos para produção de uma proteína purificada de interesse utilizando uma matriz de cromatografia de afinidade (ca), e de um anticorpo purificado, fragmento de anticorpo ou proteína de fusão de fc utilizando a coluna de proteína a".
JP2016501274A (ja) 高純度の組換えヒト血清アルブミンを単離、精製するクロマトグラフ法
JP2011525523A5 (https=)
JP2012018171A5 (https=)
PH12020500027A1 (en) Purification of iduronate-2-sulfatase
JP2013500711A5 (https=)
JP2012518034A5 (https=)
JP2016519137A5 (https=)
GB2443505B (en) Nucleic acid purification method
JP2008505133A5 (https=)
JP2008508859A5 (https=)
JP2013503877A5 (https=)
RU2014111820A (ru) Способы элиминации вируса
WO2010151632A8 (en) Protein purification by caprylic acid (octanoic acid ) precipitation
JP2014507368A5 (https=)
RU2011125656A (ru) Очистка полипептидов
FI3395423T3 (fi) Vuotaneen affiniteettipuhdistusligandin poistaminen
CN103725664A (zh) 一种高度纯化激肽释放酶的方法
TWI679209B (zh) 使用陽離子交換層析法純化同功抗體之方法
JP2014193838A5 (https=)
JP2008517046A5 (https=)